BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18374587)

  • 1. Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1.
    Homayouni R; Rice DS; Sheldon M; Curran T
    J Neurosci; 1999 Sep; 19(17):7507-15. PubMed ID: 10460257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FE65 proteins regulate NMDA receptor activation-induced amyloid precursor protein processing.
    Suh J; Lyckman A; Wang L; Eckman EA; Guénette SY
    J Neurochem; 2011 Oct; 119(2):377-88. PubMed ID: 21824144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The P's and Q's of cellular PrP-Aβ interactions.
    Westaway D; Jhamandas JH
    Prion; 2012; 6(4):359-63. PubMed ID: 22874673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids.
    Howell BW; Lanier LM; Frank R; Gertler FB; Cooper JA
    Mol Cell Biol; 1999 Jul; 19(7):5179-88. PubMed ID: 10373567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid beta precursor protein and prion protein have a conserved interaction affecting cell adhesion and CNS development.
    Kaiser DM; Acharya M; Leighton PL; Wang H; Daude N; Wohlgemuth S; Shi B; Allison WT
    PLoS One; 2012; 7(12):e51305. PubMed ID: 23236467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin-tagging of amyloid precursor protein and prion proteins.
    Taguchi Y; Shi ZD; Ruddy B; Dorward DW; Greene L; Baron GS
    Mol Biol Cell; 2009 Jan; 20(1):233-44. PubMed ID: 18987338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of co-isogenic prion protein deficient mice reveals behavioral deficits, learning impairment, and enhanced hippocampal excitability.
    Matamoros-Angles A; Hervera A; Soriano J; Martí E; Carulla P; Llorens F; Nuvolone M; Aguzzi A; Ferrer I; Gruart A; Delgado-García JM; Del Río JA
    BMC Biol; 2022 Jan; 20(1):17. PubMed ID: 35027047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies.
    Mata A; Urrea L; Vilches S; Llorens F; Thüne K; Espinosa JC; Andréoletti O; Sevillano AM; Torres JM; Requena JR; Zerr I; Ferrer I; Gavín R; Del Río JA
    Mol Neurobiol; 2017 Oct; 54(8):6412-6425. PubMed ID: 27726110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canonical and Non-canonical Reelin Signaling.
    Bock HH; May P
    Front Cell Neurosci; 2016; 10():166. PubMed ID: 27445693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functions of the cellular prion protein, the end of Moore's law, and Ockham's razor theory.
    del Río JA; Gavín R
    Prion; 2016; 10(1):25-40. PubMed ID: 26890218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β Activates Microglia and Regulates Protein Expression in a Manner Similar to Prions.
    Tu J; Chen B; Yang L; Qi K; Lu J; Zhao D
    J Mol Neurosci; 2015 Jun; 56(2):509-18. PubMed ID: 25869610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrP106-126 and Aβ 1-42 peptides induce BV-2 microglia chemotaxis and proliferation.
    Tu J; Yang L; Zhou X; Qi K; Wang J; Kouadir M; Xu L; Yin X; Zhao D
    J Mol Neurosci; 2014 Jan; 52(1):107-16. PubMed ID: 24222374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases.
    Calero O; Bullido MJ; Clarimón J; Frank-García A; Martínez-Martín P; Lleó A; Rey MJ; Rábano A; Blesa R; Gómez-Isla T; Valdivieso F; de Pedro-Cuesta J; Ferrer I; Calero M
    PLoS One; 2011; 6(7):e22090. PubMed ID: 21799773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.
    Gavín R; Ureña J; Rangel A; Pastrana MA; Requena JR; Soriano E; Aguzzi A; Del Río JA
    Neurobiol Dis; 2008 May; 30(2):243-54. PubMed ID: 18374587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Dab1 in APP processing and beta-amyloid deposition in sporadic Creutzfeldt-Jakob patients.
    Gavín R; Ferrer I; del Río JA
    Neurobiol Dis; 2010 Feb; 37(2):324-9. PubMed ID: 19853035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
    Cater MA; McInnes KT; Li QX; Volitakis I; La Fontaine S; Mercer JF; Bush AI
    Biochem J; 2008 May; 412(1):141-52. PubMed ID: 18248325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.
    Lorenzo A; Yuan M; Zhang Z; Paganetti PA; Sturchler-Pierrat C; Staufenbiel M; Mautino J; Vigo FS; Sommer B; Yankner BA
    Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein.
    Hooper NM
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):335-8. PubMed ID: 15787600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRP in amyloid-beta production and metabolism.
    Bu G; Cam J; Zerbinatti C
    Ann N Y Acad Sci; 2006 Nov; 1086():35-53. PubMed ID: 17185504
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.